Tag Archives: qval

How To Find The Best Style ETFs: Q4’15

Summary The large number of ETFs hurts investors more than it helps as too many options become paralyzing. Performance of an ETFs holdings are equal to the performance of an ETF. Our coverage of ETFs leverages the diligence we do on each stock by rating ETFs based on the aggregated ratings of their holdings. Finding the best ETFs is an increasingly difficult task in a world with so many to choose from. How can you pick with so many choices available? Don’t Trust ETF Labels There are at least 60 different All Cap Blend ETFs and at least 281 ETFs across all investment styles. Do investors need 23+ choices on average per style? How different can the ETFs be? Those 60 All Cap Blend ETFs are very different. With anywhere from 29 to 3792 holdings, many of these All Cap Blend ETFs have drastically different portfolios, creating drastically different investment implications. The same is true for the ETFs in any other style, as each offers a very different mix of good and bad stocks. Large Cap Value ranks first for stock selection. Small Cap Blend ranks last. Details on the Best & Worst ETFs in each style are here . A Recipe for Paralysis By Analysis We firmly believe ETFs for a given style should not all be that different. We think the large number of All Cap Blend (or any other) style ETFs hurts investors more than it helps because too many options can be paralyzing. It is simply not possible for the majority of investors to properly assess the quality of so many ETFs. Analyzing ETFs, done with the proper diligence, is far more difficult than analyzing stocks because it means analyzing all the stocks within each ETF. As stated above, that can be as many as 3792 stocks, and sometimes even more, for one ETF. Any investor worth his salt recognizes that analyzing the holdings of an ETF is critical to finding the best ETF. Figure 1 shows our top rated ETF for each style. Note there are no All Cap Growth or All Cap Value ETFs under coverage. Figure 1: The Best ETF in Each Style (click to enlarge) Sources: New Constructs, LLC and company filings How to Avoid “The Danger Within” Why do you need to know the holdings of ETFs before you buy? You need to be sure you do not buy an ETF that might blow up. Buying an ETF without analyzing its holdings is like buying a stock without analyzing its business and finances. No matter how cheap, if it holds bad stocks, the ETF’s performance will be bad. Don’t just take my word for it, see what Barron’s says on this matter. PERFORMANCE OF ETF’S HOLDINGS = PERFORMANCE OF ETF If Only Investors Could Find Funds Rated by Their Holdings The ValueShares US Quantitative Value ETF (BATS: QVAL ) is the top-rated All Cap Blend ETF and the overall best ETF of the 281 style ETFs that we cover. The worst ETF in Figure 1 is the State Street SPDR S&P Small Cap Growth ETF (NYSEARCA: SLYG ), which gets a Neutral rating. One would think ETF providers could do better for this style. Disclosure: David Trainer and Blaine Skaggs receive no compensation to write about any specific stock, style, or theme

Digging Beneath The Surface Of 2 Concentrated Value ETFs

Summary We have seen a big shift in investor appetite away from traditional value companies and into high flying growth names over the last several years. The August correction may afford an opportunity to purchase value ETFs at attractive prices when compared to broad equity benchmarks. Two relatively new ETFs came across my watch list as potential candidates for investors seeking an outside the box approach to value selection screens. We have seen a big shift in investor appetite away from traditional value companies and into high flying growth names over the last several years. That trend has continued in 2015, yet the recent volatility may have investors reconsidering the fundamental qualities of the stocks in their portfolio. Growth stocks tend to fall harder during corrective phases as investors flock to the safety of defensive or value-oriented sectors. Furthermore, the August correction may afford an opportunity to purchase value ETFs at attractive prices when compared to broad equity benchmarks. Two relatively new ETFs came across my watch list as potential candidates for investors seeking an outside the box approach to value selection screens. Both funds are built using a more concentrated portfolio focused on stocks with solid balance sheets and sound business qualities. ValueShares U.S. Quantitative Value ETF (BATS: QVAL ) QVAL is an actively managed ETF that debuted in late 2014 and has amassed over $50 million in assets spread amongst 40-50 individual holdings. This fund is managed by Wesley R. Gray, Ph.D. who has written extensively on the attributes of quantitative values and behavioral finance. QVAL uses three separate screening criteria to hone in on a focused number of stocks that it believes offer solid value alongside quality long-term business fundamentals. The goal is to invest in the cheapest, high quality stocks in order to try and outperform a more passive index. QVAL benchmarks its performance versus the iShares S&P 500 Value ETF (NYSEARCA: IVE ) and so far this year it has been able to maintain a similar total return. Prior to the recent correction, this actively managed ETF was actually significantly outperforming the passively managed yardstick. It’s worth pointing out that IVE is a market cap weighted index of 359 holdings, while QVAL takes a more equal weighted approach to its portfolio construction methodology. In addition, QVAL charges an expense ratio of 0.79%, compared to 0.18% for its passive counterpart. The significantly higher fees of the actively managed portfolio are to be expected for a unique strategy using proprietary screening and construction methodologies. Nevertheless, QVAL needs to prove that its approach adds value (pardon the pun) to investors that choose to step outside the passive index realm. In my opinion, this fund should warrant consideration for those seeking an alpha generating strategy for the value sleeve of their equity portfolio. Deep Value ETF (NYSEARCA: DVP ) DVP is another value-oriented strategy that debuted in 2014. This fund is based on the TWM Deep Value Index, which is constructed of 20 dividend paying stocks within the S&P 500 Index with solid balance sheets, earnings and strong free cash flow. According to the fund company website, the companies within the index are weighted based on a “rules-based assessment of their valuations so that stocks that are most attractively valued receive a higher weight.” In addition, the index is reconstituted annually. The extremely concentrated nature of the DVP portfolio makes for an interesting study in what is essentially a smart-beta index. The smaller number of holdings will likely create a greater divergence from the benchmark than a more traditional approach. This ETF will be more susceptible to individual business risks and opportunities of the underlying stocks than its peers as well. I would expect that the DVP portfolio will experience pronounced periods of underperformance and outperformance depending on the prevailing market environment . DVP has managed to accumulate over $200 million in total assets and charges a similar expense ratio as QVAL at 0.80%. This ETF is certainly worth a look for investors that like the comfort of a passive index with a stock picker’s mentality. The Bottom Line There are pros and cons to selecting ETFs that fall outside the traditional realm of low-cost and well-diversified benchmarks. However, both of these funds offer a unique approach to value investing that should not be overlooked. They can potentially add value as tactical positions that compliment your core ETF portfolio. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More…) I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article. Additional disclosure: David Fabian, FMD Capital Management, and/or clients may hold positions in the ETFs and mutual funds mentioned above. The commentary does not constitute individualized investment advice. The opinions offered herein are not personalized recommendations to buy, sell, or hold securities.

Aetna Finally Agrees To Buy Humana: ETFs In Focus

The insurance corner of the health care sector has been the hottest lately as the five big managed health care insurers are in talks of consolidation. In the latest match-up merger game between Aetna (NYSE: AET )-Humana (NYSE: HUM ) and Aetna-UnitedHealth (NYSE: UNH ), it seems that Humana has finally won following weeks of speculation. Aetna-Humana Deal in Focus In the deal announced on the eve of the July Fourth weekend, Aetna will buy Humana for about $37 billion, or about $230 per share in a cash-and-stock deal. Per the terms, Aetna will pay $125 in cash to Humana shareholders, a 23% premium to its closing price as of June 2, and 0.8375 share for each Humana share. Aetna’s shareholders will own about 74% in the combined company, while Humana’s shareholders will own the rest. The combination, if successful, would be the largest ever in the managed health care insurance space, dwarfing the recently announced $28 billion takeover offer of Chubb Corp. (NYSE: CB ) by ACE (NYSE: ACE ) and Anthem’s (NYSE: ANTM ) $16.6 billion purchase of WellPoint in 2004. The deal would push Aetna close to the second-largest insurer – Anthem – in terms of membership and would nearly triple its market share in the rapidly growing Medicare Advantage business. It will also bolster Aetna’s presence in the state and federally funded Medicaid program and Tricare coverage for military personnel and their families. With this, the combined company is expected to generate revenues of $115 billion in 2015, with 56% coming from government-sponsored programs such as Medicare and Medicaid. The acquisition, expected to be completed in the second half of next year, has already been approved by the board of directors of both companies and is seeking approvals from the shareholders and regulators. The transaction will be neutral to earnings in 2016 but accretive to earnings in mid single digits in 2017 and low double digits in 2018. The proposed merger has put the spotlight on the iShares U.S. Healthcare Providers ETF (NYSEARCA: IHF ), which could be the best way for investors to tap the opportunity arising from the AET-HUM deal. The shares of HUM are up 3.4% in the pre-market trading today while Aetna dropped over 6%. IHF in Focus This ETF follows the Dow Jones U.S. Select Healthcare Providers Index with exposure to companies that provide health insurance, diagnostics and specialized treatment. In total, the fund holds 51 securities in its basket with Aetna occupying the third position accounting for 6.6% share and Humana taking up the seventh spot at 4.6%. The fund has amassed over $1 billion in its asset base while volume is moderate at about 87,000 shares per day on average. It charges 43 bps in annual fees and expenses and has gained 20.4% so far this year. The product has a Zacks ETF Rank of 1 or ‘Strong Buy’ rating with a Medium risk outlook. Other ETF Options While IHF is undoubtedly the solid pick in the health care space to take advantage of the planned merger, other choices are also available from the large-cap space. Among them, the ValueShares U.S. Quantitative Value ETF (BATS: QVAL ) provides a decent exposure to both Aetna and Humana with a combined share of 5.8%. The ETF invests in the cheapest highest quality value stocks, holding 41 stocks in its basket. It has amassed $55.5 million in its asset base while volume is paltry at around 16,000 shares. It charges 79 bps in annual fees. The Direxion iBillionaire Index ETF (NYSEARCA: IBLN ) could also be the way to capitalize gains resulting from the Aetna-Humana deal. The fund provides an opportunity to invest like billionaires by tracking the iBillionaire Index. It has an equal-weighted portfolio of 31 large-cap stocks with Humana as one of its holdings. The product has AUM of $31.7 million and charges 65 bps in fees from investors. Volume is low, exchanging 12,000 shares in hand per day. Original Post